Lixte Biotechnology Holdings, Inc.
LIXT
Revenue
0.00
0.000.00%
3 Months ChangeAssets
2.67M
▼-921.60k▼-25.68%
3 Months ChangeLiabilities
218.65k
▼-54.79k▼-20.04%
24 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-23
Form 8-K
ID: 0001493152-24-042172
2024-09-05
Form 8-K
ID: 0001493152-24-035144
2024-08-26
Form 8-K
ID: 0001493152-24-033870
2024-08-23
Form 8-K
ID: 0001493152-24-033705
2024-08-19
Form 8-K
ID: 0001493152-24-033144
2024-08-08
Form 10-Q
ID: 0001493152-24-030757
2024-07-12
Form 8-K
ID: 0001493152-24-027085
2024-07-11
Form 8-K
ID: 0001493152-24-026924
2024-06-14
Form 8-K
ID: 0001493152-24-023834
2024-06-14
Form 8-K
ID: 0001493152-24-023798